These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6526389)

  • 1. Isobutyl-2-cyanoacrylate pulmonary emboli associated with occlusive embolotherapy of cerebral arteriovenous malformations.
    Coard K; Silver MD; Perkins G; Fox AJ; Vinuela EV
    Histopathology; 1984 Nov; 8(6):917-26. PubMed ID: 6526389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with bucrylate (isobutyl-2-cyanoacrylate) embolization of cerebral arteriovenous malformations during surgery.
    Whittle IR; Johnston IH; Besser M; Lamond TS; de Silva M
    Surg Neurol; 1983 May; 19(5):442-9. PubMed ID: 6845158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term pathological follow-up of cerebral arteriovenous malformations treated by embolization with bucrylate.
    Vinters HV; Lundie MJ; Kaufmann JC
    N Engl J Med; 1986 Feb; 314(8):477-83. PubMed ID: 3511383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular use of isobutyl 2-cyanoacrylate: Part 1 Treatment of intracranial arteriovenous malformations.
    Samson D; Ditmore QM; Beyer CW
    Neurosurgery; 1981 Jan; 8(1):43-51. PubMed ID: 7207772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embolization of cerebral arteriovenous malformations with bucrylate. Experience in a first series of 29 patients.
    Berthelsen B; Löfgren J; Svendsen P
    Acta Radiol; 1990 Jan; 31(1):13-21. PubMed ID: 2340219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative embolisation of cerebral arteriovenous malformations with isobutyl-2-cyanoacrylate (bucrylate).
    de Lange JJ; Baerts WD; Pearce C
    Acta Anaesthesiol Belg; 1982; 33(3):211-4. PubMed ID: 6815977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cyanoacrylate pulmonary embolism after embolization of a cerebral arteriovenous malformation. Report of one case].
    Fernández P; Loayza P; Sabbagh E; Badilla L; Rojas D; Verschae G; Milet B
    Rev Med Chil; 2004 Apr; 132(4):489-92. PubMed ID: 15382522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up.
    Rao VR; Mandalam KR; Gupta AK; Kumar S; Joseph S
    AJNR Am J Neuroradiol; 1989; 10(1):135-41. PubMed ID: 2492713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive thrombosis of brain arteriovenous malformations after embolization with isobutyl 2-cyanoacrylate.
    Viñuela F; Fox AJ; Debrun G; Drake CG; Peerless SJ; Girvin JP
    AJNR Am J Neuroradiol; 1983; 4(6):1233-8. PubMed ID: 6419564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological studies of human arteriovenous malformations. Effects of isobutyl 2-cyanoacrylate embolization.
    Klara PM; George ED; McDonnell DE; Pevsner PH
    J Neurosurg; 1985 Sep; 63(3):421-5. PubMed ID: 4020470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadvertent bucrylate pulmonary embolization: a case report.
    Takasugi JE; Shaw C
    J Thorac Imaging; 1989 Oct; 4(4):71-3. PubMed ID: 2607568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of arteriovenous malformations embolized with isobutyl-2-cyanoacrylate (bucrylate). Report of two cases.
    Vinters HV; Debrun G; Kaufmann JC; Drake CG
    J Neurosurg; 1981 Nov; 55(5):819-25. PubMed ID: 7310505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic pulmonary complications from liquid acrylate embolization of brain arteriovenous malformations.
    Pelz DM; Lownie SP; Fox AJ; Hutton LC
    AJNR Am J Neuroradiol; 1995 Jan; 16(1):19-26. PubMed ID: 7900592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant-hemisphere arteriovenous malformations: therapeutic embolization with isobutyl-2-cyanoacrylate.
    Viñuela FV; Debrun GM; Fox AJ; Girvin JP; Peerless SJ
    AJNR Am J Neuroradiol; 1983; 4(4):959-66. PubMed ID: 6410882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-operative embolization of cerebral arteriovenous malformations by means of isobutylcyanoacrylate (experience in 20 cases).
    Deruty R; Lapras C; Patet JD; Bascoulergue Y; Pialat J; Honorato D
    Neurol Res; 1986 Jun; 8(2):109-13. PubMed ID: 2875404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rolandic arteriovenous malformations: improvement in limb function by IBC embolization.
    Fox AJ; Girvin JP; Viñuela F; Drake CG
    AJNR Am J Neuroradiol; 1985; 6(4):575-82. PubMed ID: 3927674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary emboli following therapeutic embolization of cerebral arteriovenous malformations in children.
    Kjellin IB; Boechat MI; Vinuela F; Westra SJ; Duckwiler GR
    Pediatr Radiol; 2000 Apr; 30(4):279-83. PubMed ID: 10789913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embolization of cerebral arteriovenous malformations with bucrylate.
    Debrun G; Vinuela F; Fox A; Drake CG
    J Neurosurg; 1982 May; 56(5):615-27. PubMed ID: 7069472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balloon treatment of cerebrovascular lesions.
    Martins AN
    J Neurosurg; 1979 Apr; 50(4):537. PubMed ID: 370351
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative embolization of brain AVMs with isobutyl-2 cyanoacrylate.
    Pelz DM; Fox AJ; Viñuela F; Drake CC; Ferguson GG
    AJNR Am J Neuroradiol; 1988; 9(4):757-64. PubMed ID: 3135720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.